With COVID-19 cases rising again worldwide and pandemic fatigue setting in, all eyes are on the pharma industry in the pursuit of a COVID vaccine. Mike Ferguson talks to pharma credit analyst Tulip Lim about how pharma companies are ensuring affordability and access, how they're responding to pressure, and how prepared the industry is to face the pandemic. After, Mike and Corinne catch up on the dynamics between the many stakeholders watching vaccine development closely--including the public and governments.
Related Article: COVID-19 May Accelerate Disruption In The Global Vaccine Market